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Abstract
The evolutionary mechanisms by which SARS-CoV-2 viruses adapt to mammalian hosts
and, potentially, undergo antigenic evolution depend on the ways genetic variation is gener-
ated and selected within and between individual hosts. Using domestic cats as a model, we
show that SARS-CoV-2 consensus sequences remain largely unchanged over time within
hosts, while dynamic sub-consensus diversity reveals processes of genetic drift and weak
purifying selection. We further identify a notable variant at amino acid position 655 in Spike
(H655Y), which was previously shown to confer escape from human monoclonal antibodies.
This variant arises rapidly and persists at intermediate frequencies in index cats. It also
becomes fixed following transmission in two of three pairs. These dynamics suggest this
site may be under positive selection in this system and illustrate how a variant can quickly
arise and become fixed in parallel across multiple transmission pairs. Transmission of
SARS-CoV-2 in cats involved a narrow bottleneck, with new infections founded by fewer
than ten viruses. In RNA virus evolution, stochastic processes like narrow transmission bot-
tlenecks and genetic drift typically act to constrain the overall pace of adaptive evolution.
Our data suggest that here, positive selection in index cats followed by a narrow transmis-
sion bottleneck may have instead accelerated the fixation of S H655Y, a potentially benefi-
cial SARS-CoV-2 variant. Overall, our study suggests species- and context-specific
adaptations are likely to continue to emerge. This underscores the importance of continued
genomic surveillance for new SARS-CoV-2 variants as well as heightened scrutiny for sig-
natures of SARS-CoV-2 positive selection in humans and mammalian model systems.
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Author summary
Through ongoing human adaptation, spill-back events from other animal intermediates, or
with the distribution of vaccines and therapeutics, the landscape of SARS-CoV-2 genetic
variation is certain to change. The evolutionary mechanisms by which SARS-CoV-2 will
continue to adapt to mammalian hosts depend on genetic variation generated within and
between hosts. Here, using domestic cats as a model, we show that within-host SARS-CoV-
2 genetic variation is predominantly influenced by genetic drift and purifying selection.
Transmission of SARS-CoV-2 between hosts is defined by a narrow transmission bottle-
neck, involving 2–5 viruses. We further identify a notable variant at amino acid position 655
in Spike (H655Y), which arises rapidly and is transmitted in cats. Spike H655Y has been
previously shown to confer escape from human monoclonal antibodies and is currently
found in over 1,000 human sequences. Overall, our study suggests species- and context-spe-
cific adaptations are likely to continue to emerge, underscoring the importance of continued
genomic surveillance in humans and non-human mammalian hosts.
Introduction
Understanding the forces that shape genetic diversity of RNA viruses as they replicate within,
and are transmitted between, hosts may aid in forecasting the future evolutionary trajectories of
viruses on larger scales. The level and duration of protection provided by vaccines, therapeutics,
and natural immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
will depend in part on the amount of circulating viral variation and the rate at which adaptive
mutations arise within hosts, are transmitted between hosts, and become widespread. Here, to
model the evolutionary capacity of SARS-CoV-2 within and between hosts, we characterize viral
genetic diversity arising, persisting, and being transmitted in domestic cats.
A translational animal model can serve as a critical tool to study within- and between-host
genetic variation of SARS-CoV-2 viruses. SARS-CoV-2 productively infects Syrian hamsters,
rhesus macaques, cynomolgus macaques, ferrets, cats, and dogs in laboratory experiments.
Natural infection with SARS-CoV-2 has also been documented in ferrets, mink, dogs, and
small and large cats. This makes each of these potentially viable animal models, apart from
large cats which are not typically used in biomedical research [1–5]. Among these species, nat-
ural transmission has only been observed in mink, cats, and ferrets [1,6,7]. Transmission from
humans to mink and back to humans has also been recently documented [8]. Infectious virus
has been recovered from various upper- and mid-respiratory tissues in cats and ferrets, includ-
ing nasal turbinates, soft palate, tonsils, and trachea [1,6]. However, only in cats has infectious
virus been recovered from lung parenchyma, where infection is most commonly linked to
severe disease in humans [1,6,9,10].
Transmission bottlenecks, dramatic reductions in viral population size at the time of trans-
mission, play an essential role in the overall pace of respiratory virus evolution [11–20]. For
example, in humans airborne transmission of seasonal influenza viruses appears to involve a
narrow transmission bottleneck, with new infections founded by as few as 1–2 genetically dis-
tinct viruses [12,13,16–18]. In the absence of selection acting during a transmission event, the
likelihood of a variant being transmitted is equal to its frequency in the index host at the time
of transmission (e.g. a variant at 5% frequency, has a 5% chance of being transmitted) [21].
When transmission involves the transfer of very few variants and selection is negligible, even
beneficial variants present at low frequencies in the transmitting host are likely to be lost.
Accordingly, although antigenic escape variants can sometimes be detected at very low levels
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in individual human hosts, transmission of these variants has not been observed in nature
[22–23]. In this way, narrow transmission bottlenecks are generally expected to slow the pace
of seasonal influenza virus adaptation [11,24] and may have similar effects on SARS-CoV-2.
Accurate estimates of the SARS-CoV-2 transmission bottleneck size will therefore aid in
forecasting future viral evolution. Previous studies have reported discordant estimates of
SARS-CoV-2 transmission bottleneck sizes in humans, ranging from “narrow” bottlenecks
involving 1–8 virions to “wide” bottlenecks involving 100–1,000 virions [25–28]. However,
studies of natural viral transmission in humans can be confounded by uncertainties regarding
the timing of infection and directionality of transmission, and longitudinal samples that can
help resolve such ambiguities are rarely available. Animal models overcome many of these
uncertainties by providing access to longitudinal samples in well-defined index and contact
infections with known timing.
Here we use a cat transmission model to show that SARS-CoV-2 genetic diversity is largely
shaped by genetic drift and purifying selection, with the notable exception of a single variant
in Spike at residue 655 (H655Y). These findings are in broad agreement with recent analyses
of evolutionary forces acting on SARS-CoV-2 in humans, suggesting human SARS-CoV-2 iso-
lates are relatively well-adapted to feline hosts [25–32]. While estimates of the size of the
SARS-CoV-2 transmission bottleneck remain highly discordant in humans, we find very nar-
row transmission bottlenecks in cats, involving transmission of only 2–5 viruses. Our findings
show cat models recapitulate key aspects of SARS-CoV-2 evolution in humans and we posit
that the cat transmission model will be useful for investigating within- and between-host evo-
lution of SARS-CoV-2 viruses.
Results
Within-host diversity of SARS-CoV-2 in cats is limited
Recently, members of our team inoculated three domestic specific-pathogen free cats with a
second-passage SARS-CoV-2 human isolate from Tokyo (hCoV-19/Japan/UT-NCGM02/
2020) [33]. Each index cat was co-housed with a contact cat beginning on day 1 post-inocula-
tion (DPI). No new cat infections were performed for this study. Nasal swabs were collected
daily up to 10 days post-inoculation, Fig 1. Viral RNA burden is plotted in S1A Fig and infec-
tious viral titers are shown in S1B Fig.
Using conservative frequency thresholds previously established for tiled-amplicon sequencing,
we called within-host variants (both intrahost single-nucleotide variants “iSNVs” and short inser-
tions and deletions “indels”) throughout the genome against the inoculum SARS-CoV-2 reference
(Genbank: MW219695.1) [34,35]. Variants were required to be present in technical replicates at
�3% and�97% of sequencing reads [36] (all within-host variants detected at>97% frequency
were assumed to be fixed; see Methods for details). iSNVs were detected at least once at 38 different
genome sites. Of the 38 unique variants, 14 are synonymous changes, 23 are nonsynonymous
changes, and one occurs in an intergenic region; this distribution is broadly similar to recent reports
of SARS-CoV-2 variation in infected humans [30]. Similarly, we detected indels occurring at 11 dif-
ferent genome sites across all animals and timepoints. We identified 6–19 distinct variants per cat,
of which 4–7 were observed on two or more days over the course of the infection within each cat
(S2 Fig). All variants (iSNVs and indels) are plotted by genome location and frequency in Fig 2A.
Genetic drift and purifying selection shape within-host diversity
To probe the evolutionary pressures shaping SARS-CoV-2 viruses within hosts, we first evalu-
ated the proportion of variants shared between cats. Eighty-nine percent of variants (34 of 38
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iSNVs and 8 of 11 indels) were found in a single cat (42/49), 8% of variants were found in 2–5
cats (4/49), and the remaining 6% of variants were found in all 6 cats (3/49).
Purifying selection, which acts to purge deleterious mutations from a population, is known
to result in an excess of low-frequency variants. In contrast, positive selection results in the
accumulation of intermediate- and high-frequency variation [37]. Especially in the setting of
an acute viral infection, exponential population growth is also expected to result in an excess
of low-frequency variants [38]. To determine the type of evolutionary pressure acting on
SARS-CoV-2 in cats, we plotted these distributions against a simple “neutral model” (light
grey bars in Fig 2B), which assumes a constant population size and the absence of selection
[37]. This model predicted that ~43% of polymorphisms would fall in the 3–10% frequency
bin, ~25% into the 10–20% bin, ~14% into the 20–30% bin, ~10% into the 30–40% bin, and
~8% into the 40–50% bin. The frequency distribution of variants detected in each index cat
across all available timepoints did not differ significantly from this “neutral” expectation
(p = 0.265, p = 0.052, p = 0.160, respectively; Mann Whitney U test).
Next we compared nonsynonymous (πN) and synonymous (πS) pairwise nucleotide diver-
sity to further evaluate the evolutionary forces shaping viral populations in index and contact
animals [39]. Broadly speaking, excess nonsynonymous polymorphism (πN/πS > 1) points
toward diversifying or positive selection while excess synonymous polymorphism (πN/πS < 1)
indicates purifying selection. When πN / πS is approximately 1, genetic drift, i.e., stochastic
changes in the frequency of viral genotypes over time, can be an important force shaping
genetic diversity. We observe that πS exceeds or is approximately equal to πN in most genes,
although there is substantial variation among genes and cats (S1 Table, S10 and S11 Figs). πS
is significantly higher than πN in all 3 index cats in Spike (p = 0.005, p = 0.004, p = 0.019,
unpaired t-test) and ORF1ab (p = 2.11e-05, p = 1.84e-06, p = 1.99e-06, unpaired t-test) and in
Fig 1. Experimental timeline. Schematic representing the sampling timeline for the three transmission pairs. Index cats were inoculated on day 0 with 5.2e5 PFU of a
human isolate (hCoV-19/Japan/UT-NCGM02/2020) and were co-housed with a naive cat starting on day 1. Within each transmission pair, the top row of circles
represents the index cat and the bottom row represents the contact cat. Open circles represent days on which there was no detectable infectious virus as indicated by
plaque assay, and closed circles highlight days when live virus was recovered. Circles with a red outline indicate timepoints which were used in the beta-binomial
estimate to calculate transmission bottleneck sizes.
https://doi.org/10.1371/journal.ppat.1009373.g001
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index cats 2 and 3 in ORF8 (p = 0.03, p = 0.04, unpaired t-test). πS and πN are not significantly
different in at least one index cat in ORF3a, envelope, and nucleocapsid. There was not enough
genetic variation to measure nucleotide diversity in the remaining four genes (S1 Table).
Taken together, these results suggest longitudinal genetic variation within feline hosts is prin-
cipally shaped by genetic drift with purifying selection acting on individual genes, particularly
ORF1ab and Spike.
Longitudinal sampling reveals few consensus-level changes within hosts
The consensus sequences recovered from all three index cats on the first day post-inoculation
was identical to the inoculum or “stock” virus. This consensus sequence remained largely
unchanged throughout infection in all index cats with the notable exception of two variants:
H655Y in Spike (nucleotide site 23,525) and a synonymous change at amino acid position 67
in envelope (nucleotide site 26,445; S67S), which arose rapidly in all 3 index cats and rose to
consensus levels (�50% frequency) at various timepoints throughout infection in all index
cats. Neither of these iSNVs were detected above 3% frequency in the inoculum, but when we
mined all sequencing reads, S H655Y and E S67S could be detected at 0.85% and 0.34%,
Fig 2. Within-host diversity of SARS-CoV-2 viruses in domestic cats. A) Plot representing all variants (iSNVs and indels) detected in any cat at any timepoint. Variant
frequencies are plotted by genome location and are colored by gene. Circles represent synonymous iSNVs, squares represent nonsynonymous iSNVs, and stars represent
indels. B) iSNV frequency spectrums with error bars showing standard deviation for index cats plotted against a “neutral model” (light gray bars) which assumes a
constant population size and the absence of selection.
https://doi.org/10.1371/journal.ppat.1009373.g002
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respectively. S H655Y was the consensus sequence on days 2–5 and days 7–8 in index cat 1, as
well as on days 4 and 8 in index cat 2, and remained detectable above our 3% variant threshold
throughout infection (Fig 3). Similarly, envelope S67S (E S67S) was the consensus sequence
on day 8 in index cat 1 and day 1 in index cat 2. S H655Y and E S67S were detectable on days
1–7 in cat 3 but stayed below consensus level.
Interestingly, S H655Y and E S67S became fixed together following transmission in two
transmission pairs (contact cats 4 and 6) and were lost together during transmission to contact
animal 5. In cat 5, however, two different variants in ORF1ab, G1756G and L3606F, became
Fig 3. Frequency of iSNVs over time in each index and contact cat. The frequency of iSNVs discussed in the results over time in all six cats are shown. All iSNVs over
time are shown in S2 Fig and all indels over time are shown in S3 Fig. Each variant is colored by gene location. Nonsynonymous variants are plotted with solid lines and
synonymous variants are plotted with dashed lines. Variants detected in index cats are denoted with squares and variants detected in contact cats are denoted with circles.
Timepoints with viral loads too low to yield high quality sequences are shown by the gaps in data, but iSNVs are connected across these gaps using light lines for
readability (i.e. cat 1 day 9). The dotted line at 50% frequency represents the consensus threshold.
https://doi.org/10.1371/journal.ppat.1009373.g003
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fixed after transmission. ORF1ab G1756G was not detected above 3% and L3606F was found
at 17.2% in the day 5 sample from the index cat 2 (the cat transmitting to cat 5); it was not
found in the inoculum at any detectable frequency. The categorical loss or fixation of these var-
iants immediately following transmission, and in particular the fixation following transmission
of a variant that was undetectable before, are highly suggestive of a narrow bottleneck [40].
In addition, a synonymous variant in an alanine codon at amino acid position 1,222 in
Spike (nucleotide site 25,174) was found at>50% frequencies on days 4 and 8 in index cat 3,
but was not detected above 3% on any other days. All iSNVs over time are shown in S2 Fig
and all indels over time are shown in S3 Fig. These within-host analyses show that genetic
drift appears to play a prominent role in shaping low-frequency genetic variation within hosts.
SARS-CoV-2 transmission in domestic cats is defined by a narrow
transmission bottleneck
To estimate the size of SARS-CoV-2 transmission bottlenecks, we investigated the amount of
genetic diversity lost following transmission in cats. We observed a reduction in the cumula-
tive number of variants detected in each contact cat compared to its index: 7 fewer variants in
cat 4 (n = 9) compared to cat 1 (n = 16), 9 fewer in cat 5 (n = 10) than cat 2 (n = 19), and 10
fewer in cat 6 (n = 16) than cat 3 (n = 6). Likewise, the frequency distribution of variants in all
three contact cats following transmission differed from the distribution of variants in all three
index cats prior to transmission (p-value = 0.052, Mann Whitney U test). Following transmis-
sion, variant frequencies became more bimodally distributed than those observed in index
cats, i.e., in contacts, most variants were either very low-frequency or fixed (S2 Fig).
To quantitatively investigate the stringency of each transmission event, we compared the
genetic composition of viral populations immediately before and after viral transmission. We
chose to use the first timepoint when infectious virus was recovered in the contact cat coupled
with the timepoint immediately preceding this day in the index cat, as has been done previ-
ously [17]. We used days 2 (index) and 3 (contact) in pair 1, days 5 and 6 in pair 2, and days 4
and 5 in pair 3 (these sampling days are outlined in red in Fig 1). We applied the beta-binomial
sampling method developed by Sobel-Leonard et al. to compare the shared set of variants
(�3%,�97%) in the pre/post-transmission timepoints for each pair [21]. Maximum-likeli-
hood estimates determined that a mean effective bottleneck size of 5 (99% CI: 1–10), 3 (99%
CI: 1–7), and 2 (99% CI: 1–3) best described each of the three cat transmission events evaluated
here (Fig 4). This is in line with previous estimates for other respiratory viruses, including air-
borne transmission of seasonal influenza viruses in humans [40]. It is important to note, how-
ever, that the cat transmission pairs evaluated here shared physical enclosure spaces so the
route of transmission could be airborne, direct contact, fomite, or a combination of these.
Additionally, it has been shown that the route of influenza transmission can directly impact
the size of the transmission bottleneck; for example, in one study airborne transmission of
influenza viruses resulted in a narrow bottleneck, whereas contact transmission resulted in a
wider bottleneck [16].
Discussion
At the time of writing, the vast majority of humans remain immunologically naive to SARS--
CoV-2. Whether through ongoing human adaptation, spill-back events from other animal
intermediates, or with the distribution of vaccines and therapeutics, the landscape of SARS--
CoV-2 variation is certain to change. Understanding the forces that shape genetic diversity of
SARS-CoV-2 viruses within hosts will aid in forecasting the pace of genetic change as the virus
faces shifting population-level immunity. Additionally, this baseline allows researchers to
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more easily identify a shift in the forces shaping within- and between-host diversity; for exam-
ple, identification of signatures of positive selection might highlight rapidly-adapting, and
therefore higher-risk, viruses.
Using domestic cats as a model system, we show stochastic processes like narrow transmis-
sion bottlenecks and genetic drift are major forces shaping SARS-CoV-2 genetic diversity
within and between mammalian hosts. These stochastic forces typically act to constrain the
overall pace of RNA virus evolution [12]. Despite this, we observe the rapid outgrowth of S
H655Y in all three index cats, suggesting that this site may be under positive selection in this
system. This variant achieved rapid fixation following transmission in two of three transmis-
sion pairs.
Our finding of narrow transmission bottlenecks is at odds with some recent studies in
humans, which have estimated wide and variable SARS-CoV-2 transmission bottlenecks [25–
28], but it is in line with other estimates suggesting that few SARS-CoV-2 viruses are transmit-
ted between humans [25]. These discordant estimates are likely due to a combination of fac-
tors, including variable routes of transmission, uncertain sources of infection, difficulty
collecting samples which closely bookend the transmission event, and inaccurate variant calls
[25–28]. Human studies have commonly identified transmission pairs using intrahousehold
infections diagnosed within a defined timeframe. A major weakness with this approach is the
possibility that some of these cohabiting individuals will share an alternative source of expo-
sure. Furthermore, without fine-scale epidemiological and clinical metadata, pinpointing the
time of likely transmission is challenging, so even samples collected before and after a real
transmission event may be several days removed from the time of transmission. Here we were
able to circumvent many of these challenges by taking advantage of domestic cats experimen-
tally infected with SARS-CoV-2 arranged in defined transmission pairs with clinical monitor-
ing and daily sample collection, making for a useful model system.
The size of the transmission bottleneck may have additional implications for individual
infections. The total number of founding virions, or the inoculum dose, has been posited to
play a role in coronavirus disease 2019 (COVID-19) clinical severity and outcomes [41,42].
The transmission bottleneck can be parsed into two interdependent components: the
Fig 4. SARS-CoV-2 transmission is defined by a narrow bottleneck. Variant frequencies in the index cats (x-axis) compared with frequencies of the same variants in the
corresponding contact cats (y-axis) that were used in the beta-binomial estimate are shown on the left. Estimates of SARS-CoV-2 transmission bottleneck with 99%
confidence intervals shown on the right.
https://doi.org/10.1371/journal.ppat.1009373.g004
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population bottleneck, or the number of virus particles that found infection (similar to inocu-
lation dose); and the genetic bottleneck, or the amount of viral diversity lost during transmis-
sion. For example, an infection founded by 1,000 genetically identical viruses would be
categorized as resulting from a narrow genetic bottleneck (a single genotype initiates the infec-
tion) and a relatively large population bottleneck. The beta-binomial method used here mea-
sures the population bottleneck [21]. Our data are consistent with a narrow population
bottleneck and therefore a low inoculum dose in these cats. The extent to which feline hosts
experience symptoms when infected with SARS-CoV-2 is unclear, but the cats involved in this
study remained afebrile throughout the study, did not lose body weight, and experienced no
respiratory signs. Viral genetic diversity has been linked to pathogenesis and clinical outcomes
in the context of other viruses (e.g., influenza A virus, polio, and respiratory syncytial virus)
and because narrow transmission bottlenecks often reduce viral genetic diversity, bottlenecks
may play an essential role in the outcome of individual infections in this way as well [43–47].
The relationship between SARS-CoV-2 viral genetic diversity and COVID-19 clinical severity
remains unclear. Some have proposed a direct relationship between particular viral lineages
and COVID-19 severity [48], while others postulate that host factors, like age and comorbidi-
ties such as hypertension, diabetes, and preexisting respiratory system disease, are more likely
to explain variable clinical outcomes [49].
Although within-host diversity was limited in the cats evaluated here, we identify two nota-
ble variants. S H655Y and E S67S were found at 0.85% and 0.34% in the stock, but were prefer-
entially amplified in all three index cats and were detectable at intermediate frequencies at the
first-day post-inoculation. Interestingly, S H655Y is not found in any of the 18 full-genome
domestic cat, tiger, and lion SARS-CoV-2 sequences available on GISAID (S4 Fig). S H655Y
has, however, been reported in a variety of other settings, including transmission studies in a
hamster model, SARS-CoV-2 tissue culture experiments [50–53], and in a stock virus passaged
on Vero E6 cells [BioProject PRJNA645906, experiment numbers SRX9287152 (p1),
SRX9287151 (p2), SRX9287154 (p3a); BioProject PRJNA627977]. S H655Y additionally per-
sisted in vivo in rhesus macaques challenged with one of these stock viruses [BioProject
PRJNA645906, experiment number SRX9287155]. As of 28 December, 2020, S H655Y has
been detected in 1,070 human SARS-CoV-2 viruses across 18 different countries in sequences
deposited in GISAID. The majority of these sequences come from the United Kingdom
(n = 886) (S5B and S5C Fig). It is important to note, however, that sampling of SARS-CoV-2
sequences is heavily biased and sequences from the COVID-19 Genomics UK consortium
(COG-UK) are currently overrepresented in GISAID. At the time of writing, S H655Y was the
16th most common variant detected in Spike among publicly-available SARS-CoV-2 sequences
[54]. Sequences containing S H655Y variant are found in two distinct European clusters, EU1
and EU2, suggesting it has arisen more than once (S5A Fig).
Relatively little is known about the phenotypic impact of S H655Y in cats, humans, and
other host species. Amino acid residue 655 is located near the polybasic cleavage site, residing
between the receptor binding domain (RBD) and the fusion peptide, and therefore has been
hypothesized to play a role in regulating Spike glycoprotein fusion efficiency (S12 Fig)
[50,51,55]. In spite of its location outside of the RBD, S H655Y has been shown to arise on the
background of a vesicular stomatitis virus (VSV) pseudotyped virus expressing various SARS--
CoV-2 spike variants and confer escape from multiple monoclonal human antibodies in cell
culture [50]. It is unlikely S H655Y represents a site of antibody escape in these cats because
they were specific pathogen-free and had undetectable IgG antibody titers against SARS-CoV-
2 Spike and Nucleocapsid proteins on the day of infection [33]. We did not do any experi-
ments to elucidate the functional impact of this variant, but we speculate S H655Y could have
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improved Spike fusion efficiency and therefore host cell entry in cats. It is possible S H655Y
offers a similar advantage in human hosts and/or confers escape from some antibodies.
E S67S has not been documented elsewhere. Based on iSNV frequencies, S H655Y and E
S67S appear to be in linkage with each other (see mirrored iSNV frequencies in cat 2 and cat 5
in Fig 3 in particular), however with short sequence reads and sequencing approaches relying
on amplicon PCR, we cannot rigorously assess the extent of linkage disequilibrium between
these variants. It may be that S H655Y arose on the genetic background of an existing S67S var-
iant in envelope. If S H655Y facilitates viral entry or replication in cats, viruses with this variant
in linkage with E S67S might have been positively selected in all index cats.
Our data alone cannot resolve the precise mechanisms by which SARS-CoV-2 diversity is
reduced during transmission, but the trajectories of S H655Y and E S67S raise some interesting
possibilities. Although our sample size is small, the outgrowth of S H655Y with E S67S in all
index cats, and the fixation of these variants in 2 of 3 contact cats, suggest that selection for
one or both of these variants could have played a role in shaping genetic diversity recovered
from contact cats. Viruses bearing these mutations could be preferentially amplified prior to,
during, and/or after transmission.
If the transmission bottleneck is narrow and random, a variant’s likelihood of being trans-
mitted is equal to its frequency in the viral population at the time of transmission. If selection
acts primarily within index hosts prior to transmission, S H655Y could have achieved a high
enough frequency to be randomly drawn at the time of transmission. In this case, even a ran-
dom, narrow transmission bottleneck could have facilitated the rapid fixation of a putatively
beneficial variant. Next, suppose that viruses bearing S H655Y are shed more efficiently from
index animals. In this case, evidence of selection in index animals would be limited and we
would observe a small founding population in contact hosts where the beneficial variant is
dominant. Alternatively, suppose viruses bearing S H655Y preferentially found infection in
the recipient. In this case where selection is acting primarily in the contact host, transmission
may involve transfer of a larger virus population after which beneficial variants may rapidly be
swept to fixation. These scenarios are not mutually exclusive and it is possible for selection to
act in concert before, during, and after transmission. In any of these scenarios, we would
observe a low-diversity virus population in contact animals in which the putatively beneficial
variants had been enriched. Notably, S H655Y and E S67S are absent from contact cat 5 (pair
2), despite being detectable and even reaching consensus levels in the associated index animal.
While these variants are lost during transmission in this pair, a variant in ORF1ab
(Gly1756Gly), which was undetectable in index cat 2, became fixed in contact cat 5 following
transmission. The dramatic shifts in iSNV frequency we observe in all 3 pairs are characteristic
of a narrow transmission bottleneck [12]. Because narrow transmission bottlenecks can result
in the loss of even beneficial variants, the fact that S H655Y and E S67S failed to be transmitted
in pair 2 does not exclude the possibility that these variants enhance viral fitness. Altogether
our data therefore support the conclusion that SARS-CoV-2 transmission bottlenecks are nar-
row in this system, and may sometimes involve selection.
SARS-CoV-2 viruses can replicate and be shed via the respiratory tract. Differences in cell
types, receptor distribution, temperature and humidity along the length of the respiratory tract
may favor the emergence of different viral variants. If viral populations vary genetically across
anatomic location, virus collected from different parts of the respiratory tract could result in
different bottleneck size estimates. In this study, we had access to nasal swabs and therefore
were only able to evaluate genetic diversity arising in the upper respiratory tract. Others have
previously documented foci of influenza virus in the lower respiratory tract appear to be inde-
pendent from upper respiratory tract infections [56,57]. Current insights into potential
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differences in the genetic composition, structure, and evolution in the upper vs. lower respira-
tory tract remain incomplete for both influenza viruses and SARS-CoV-2.
Large SARS-CoV-2 outbreaks in mink have been reported recently, some with “concern-
ing” mutations that may evade human humoral immunity [58]. These mink outbreaks have
resulted in the Danish authorities’ decision to cull 17 million mink as a safeguard against spill-
back transmission into humans [58]. Similarly, the emergence of the B.1.1.7 SARS-CoV-2 line-
age has brought to light the importance of detecting and characterizing novel variants which
might confer increased transmissibility, infectiousness, clinical severity, or other phenotypic
change. The precise origins of the defining B.1.1.7 variants are unknown. It has been specu-
lated that it may have arisen from a chronically infected patient or through sub-curative doses
of convalescent plasma [59]. While S H655Y has not been found in mink and is not one of the
defining B.1.1.7 mutations, another one of the defining B.1.1.7 mutations, Spike N501Y, has
emerged independently in mouse models [60]. This suggests that mammalian models can
facilitate the detection of novel mutations and signatures of positive selection, which might
highlight adaptive mutations. We observe one variant that arises early and is transmitted
onward in cats, a potential reservoir and model species. Little has been specifically documented
about this variant, but it was very interesting to note it confers escape from various human
monoclonal antibodies and has been detected in more than 1,000 human viruses [50,61]. Our
study and the mink example show that species- and context-specific adaptations are likely to
continue to emerge as SARS-CoV-2 explores new hosts. Further investigation and ongoing
surveillance for such variants is warranted. It is also important to prevent the reintroduction of
such newly formed variants, of which we do not know the potential phenotypic impacts, by
limiting the spread and evolution of SARS-CoV-2 in non-human reservoir species.
As SARS-CoV-2 continues to spread globally, we must have models in place to recapitulate
key evolutionary factors influencing SARS-CoV-2 transmission. With the imminent release of
SARS-CoV-2 vaccines and therapeutics and increasing prevalence of natural exposure-related
immunity, these models can help us forecast the future of SARS-CoV-2 variation and popula-
tion-level genetic changes. Continued efforts to sequence SARS-CoV-2 across a wide variety of
hosts, transmission routes, and spatiotemporal scales will be necessary to determine the evolu-




No animal experiments were specifically performed for this study. We used residual nasal
swabs collected from domestic cats as part of a previously published study [33]. Animal studies
were approved prior to the start of the study by the Institutional Animal Care and Use Com-
mittee and performed in accordance with the Animal Care and Use Committee guidelines at
the University of Wisconsin-Madison.
Domestic cat experiments
No animal experiments were specifically performed for this study. We used residual nasal
swabs collected from domestic cats as part of a previously published study [33]. Animals used
in this study were specific-pathogen-free animals from a research colony maintained at the
University of Wisconsin-Madison and were negative for feline coronavirus. As previously
described by Halfmann et al, domestic cats were housed in 0.56 m x 0.81 m x 1.07 m cages in a
laboratory with 65% humidity at 23˚C, and with at least 15.2 air exchanges per hour. Weight
and body temperature (through implanted transponders) were measured daily (days 1–14).
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Under ketamine and dexdomitor anesthesia, three cats were inoculated with 5.2 x 105 plaque-
forming units (PFU of SARS-CoV-2 given by a combination of inoculation routes for every
animal (nasal [100 μl per nare], tracheal [500 μl], oral [500 μl], and ocular [50 μl per eye]). To
reverse the effects of the anesthesia, antisedan was administered to the animals after comple-
tion of the inoculation. Nasal swabs were collected daily during the study (days 1–10).
Nucleic acid extraction
For each sample, approximately 140 μL of viral transport medium was passed through a
0.22 μm filter (Dot Scientific, Burton, MI, USA). Total nucleic acid was extracted using the
Qiagen QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany), substituting carrier RNA
with linear polyacrylamide (Invitrogen, Carlsbad, CA, USA) and eluting in 30 μL of nuclease-
free H2O.
Complementary DNA (cDNA) generation
Complementary DNA (cDNA) was synthesized using a modified ARTIC Network approach
[34,35]. Briefly, RNA was reverse transcribed with SuperScript IV Reverse Transcriptase (Invi-
trogen, Carlsbad, CA, USA) using random hexamers and dNTPs. Reaction conditions were as
follows: 1 μL of random hexamers and 1 μL of dNTPs were added to 11 μL of sample RNA,
heated to 65˚C for 5 minutes, then cooled to 4˚C for 1 minute. Then 7 μL of a master mix
(4 μL 5x RT buffer, 1 μL 0.1M DTT, 1μL RNaseOUT RNase Inhibitor, and 1 μL SSIV RT) was
added and incubated at 42˚C for 10 minutes, 70˚C for 10 minutes, and then 4˚C for 1 minute.
Multiplex PCR for SARS-CoV-2 genomes
A SARS-CoV-2-specific multiplex PCR for Nanopore sequencing was performed, similar to
amplicon-based approaches as previously described [34,35]. In short, primers for 96 overlap-
ping amplicons spanning the entire genome with amplicon lengths of 500bp and overlapping
by 75 to 100bp between the different amplicons were used to generate cDNA. Primers used in
this manuscript were designed by ARTIC Network and are shown in S3 Table. cDNA (2.5 μL)
was amplified in two multiplexed PCR reactions using Q5 Hot-Start DNA High-fidelity Poly-
merase (New England Biolabs, Ipswich, MA, USA) using the following cycling conditions;
98˚C for 30 seconds, followed by 25 cycles of 98˚C for 15 seconds and 65˚C for 5 minutes, fol-
lowed by an indefinite hold at 4˚C [34,35]. Following amplification, samples were pooled
together before TrueSeq Illumina library prep.
TrueSeq Illumina library prep and sequencing
Amplified cDNA was purified using a 1:1 concentration of AMPure XP beads (Beckman Coul-
ter, Brea, CA, USA) and eluted in 30 μL of water. PCR products were quantified using Qubit
dsDNA high-sensitivity kit (Invitrogen, USA) and were diluted to a final concentration of 2.5
ng/μl (150 ng in 50 μl volume). Each sample was then made compatible with deep sequencing
using the TruSeq sample preparation kit (Illumina, USA). Specifically, each sample was enzy-
matically end repaired. Samples were purified using two consecutive AMPure bead cleanups
(0.6x and 0.8x) and were quantified once more using Qubit dsDNA high-sensitivity kit (Invi-
trogen, USA). A non-templated nucleotide was attached to the 30 ends of each sample, followed
by adaptor ligation. Samples were again purified using an AMPure bead cleanup (1x) and
eluted in 25 μL of resuspension buffer. Lastly, samples were amplified using 8 PCR cycles,
cleaned with a 1:1 bead clean-up, and eluted in 30 μL of RSB. The average sample fragment
length and purity was determined using the Agilent High Sensitivity DNA kit and the Agilent
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2100 Bioanalyzer (Agilent, Santa Clara, CA). After passing quality control measures, samples
were pooled equimolarly to a final concentration of 4 nM, and 5 μl of each 4 nM pool was
denatured in 5 μl of 0.2 N NaOH for 5 min. Sequencing pools were denatured to a final con-
centration of 10 pM with a PhiX-derived control library accounting for 1% of total DNA and
was loaded onto a 500-cycle v2 flow cell. Average quality metrics were recorded, reads were
demultiplexed, and FASTQ files were generated on Illumina’s BaseSpace platform.
Processing of the raw sequence data, mapping, and variant calling
Raw FASTQ files were analyzed using a workflow called “SARSquencer”. Briefly, reads are
paired and merged using BBMerge (https://jgi.doe.gov/data-and-tools/bbtools/bb-tools-user-
guide/bbmerge-guide/) and mapped to the reference (MW219695.1) using BBMap (https://jgi.
doe.gov/data-and-tools/bbtools/bb-tools-user-guide/bbmap-guide/). Mapped reads were
imported into Geneious (https://www.geneious.com/) for visual inspection. Read coverage for
index cat samples is plotted in S6 Fig and for contact samples in S7 Fig. Variants were called
using callvariants.sh (contained within BBMap) and annotated using SnpEff (https://pcingola.
github.io/SnpEff/). The complete “SARSquencer” pipeline is available in the GitHub accompa-
nying this manuscript in ‘code/SARSquencer’ as well as in a separate GitHub repository–
https://github.com/gagekmoreno/SARS_CoV-2_Zequencer. BBMap’s output VCF files were
cleaned using custom Python scripts, which can be found in the GitHub accompanying this
manuscript (https://github.com/katarinabraun/SARSCoV2_transmission_in_domestic_cats)
[60]. Variants were called at�0.01% in reads that were�100 bp in length and supported by a
minimum of 10 reads. Only variants at�3% frequency in both technical replicates were used
for downstream analysis. Variant concordance across technical replicates is plotted in S8 Fig
for index cats and S9 Fig for contact cats. In addition, all variants occurring in ARTIC v3
primer-binding sites were discarded before proceeding with downstream analysis.
Quantification of SARS-CoV-2 vRNA
Plaque forming unit analysis was performed on all nasal swabs as published in Halfmann et al.
2019 [33]. Viral load analysis was performed on all of the nasal swab samples described above
after they arrived in our laboratory. RNA was isolated using the Viral Total Nucleic Acid kit
for the Maxwell RSC instrument (Promega, Madison, WI) following the manufacturer’s
instructions. Viral load quantification was performed using a sensitive qRT-PCR assay devel-
oped by the CDC to detect SARS-CoV-2 (specifically the N1 assay) and commercially available
from IDT (Coralville, IA). The assay was run on a LightCycler 96 or LC480 instrument
(Roche, Indianapolis, IN) using the Taqman Fast Virus 1-stepMaster Mix enzyme (Thermo
Fisher, Waltham, MA). The limit of detection of this assay is estimated to be 200 genome
equivalents/ml saliva or swab fluid. To determine the viral load, samples were interpolated
onto a standard curve consisting of serial 10-fold dilutions of in vitro transcribed SARS-CoV-2
N gene RNA.
Pairwise nucleotide diversity calculations
Nucleotide diversity was calculated using π summary statistics (S2 Table). π quantifies the
average number of pairwise differences per nucleotide site among a set of sequences and was
calculated per gene using SNPGenie (https://github.com/chasewnelson/SNPgenie) [62].
SNPGenie adapts the Nei and Gojobori method of estimating nucleotide diversity (π), and its
synonymous (πS) and nonsynonymous (πN) partitions from next-generation sequencing data
[63]. When πN = πS, this indicates neutral evolution or genetic drift, with neither strong puri-
fying nor positive selection playing a large role in the evolution of the viral population. πN <
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πS indicates purifying selection is acting to remove deleterious mutations, and πN > πS shows
positive or diversifying selection acting on nonsynonymous variation [64]. We tested the null
hypothesis that πN = πS within each gene using an unpaired t-test (S1 Table). The code to rep-
licate these results can be found in the ‘diversity_estimates.ipynb’ Jupyter Notebook in the
‘code’ directory of the GitHub repository [65].
SNP Frequency Spectrum calculations
To generate SNP Frequency Spectrums (SFS), we binned all variants detected across time-
points within each index cat into six bins– 3–10%, 10–20%, 20–30%, 30–40%, 40–50%, 50–
60%. We plotted the counts of variants falling into each frequency bin using Matplotlib 3.3.2
(https://matplotlib.org). We used code written by Dr. Louise Moncla to generate the distribu-
tion of SNPs for a given population assuming no selection or change in population size, which
is expected to follow a 1/x distribution [37]. The code to replicate this can be found in the
GitHub accompanying this manuscript, specifically in the ‘code/SFS.ipynb’ Jupyter Notebook.
This model predicts 42.8% of variants will fall within the 3–10% frequency range, 24.6% will
fall within the 10–20% frequency range, 14.4% of variants will fall within the 20–30% fre-
quency range, 10.2% of variants will fall within the 30–40% frequency range, and 7.9% of vari-
ants will fall within the 40–50% frequency range. We used a Mann-Whitney U test to test the
null hypothesis that the distribution of variant frequencies for each index cat was equal to the
neutral distribution. The code to replicate these results can be found in the ‘SFS.ipynb‘Jupyter
Notebook in the ‘code‘directory of the GitHub repository [65].
Focal Nextstrain build of S H655Y sequences
The focal H655Y build (S5 Fig) was prepared as described in Hodcroft et al. (2020), with dif-
ferent mutations targeted for the S:655 mutation [66]. Briefly: sequences with a mutation at
nucleotide position 23525 (corresponding to a change at the 655 position in the spike glyco-
protein) were selected from all available sequences on GISAID as of 29th December 2020.
These sequences were included as the ’focal’ set for a Nextstrain phylogenetic analysis, to
which ’context’ sequences were added, with the most genetically similar sequences given
priority.
Code and data availability
Code to replicate analyses and re-create most figures is available at https://github.com/
katarinabraun/SARSCoV2_transmission_in_domestic_cats [65]. Fig 1 was created by hand in
Adobe Illustrator and S6 and S7 Figs were created using samtools command line tools, were
visualized in JMP Pro 15 (https://www.jmp.com/en_in/software/new-release/new-in-jmp-
and-jmp-pro.html), and were then edited for readability in Adobe Illustrator. Code to process
sequencing data is available at https://github.com/gagekmoreno/SARS_CoV-2_Zequencer and
dependencies are available through Docker [67]. Results were visualized using Matplotlib 3.3.2
(https://matplotlib.org), Seaborn v0.10.0 (https://github.com/mwaskom/seaborn), and Baltic
v0.1.0 (https://github.com/evogytis/baltic).
Supporting information
S1 Fig. Viral loads and viral titers over time. A) Viral RNA burden over time for each cat.
Index cats are represented by a solid line and contact cats are represented by a dashed line.
Transmission pairs are denoted by color. The grey, horizontal dotted line represents when less
than ~100 copies/μL are input into the reverse transcription reaction. B) Infectious viral titer
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over time. Index cats are represented by a solid line and contact cats are represented by a
dashed line. Transmission pairs are denoted by color.
(TIF)
S2 Fig. Longitudinal frequency of iSNVs detected in all cats and at all timepoints. Each var-
iant is colored based on gene location. Nonsynonymous variants are plotted with solid lines
and synonymous variants are plotted with dashed lines. Days with viral loads too low to yield
high quality sequences are shown by the gaps in data (i.e. cat 3 day 6 and cat 4 day 9).
(TIF)
S3 Fig. Longitudinal frequency of indels detected in all cats and at all timepoints. Each
indel is colored based on gene location. Days with viral loads too low to yield high quality
sequences are shown by the gaps in data (i.e. cat 3 day 6 and cat 4 day 9). Note the y-axis range
is 0–12%, not 0–100%, to facilitate readability.
(TIF)
S4 Fig. Sequence alignment of all tiger, lion, and domestic cat sequences available in
GISAID as of December 2020. Sequences were aligned against MW219695.1, the inoculum
virus used in these experiments. Consensus-level differences are highlighted with a blue verti-
cal marker. Indels are noted with a horizontal vertical marker. The spike open reading frame is
annotated with a green marker and site amino acid 655 in Spike is highlighted with the orange
box. None of these sequences contain a consensus mutation at residue 655 in Spike.
(TIF)
S5 Fig. Geographic dispersion of Spike H655Y variant. A) A time-resolved phylogeny
focused on viruses that contain Spike H655Y. Viruses that contain histidine (H) at Spike 655
are colored in teal. Viruses with tyrosine (Y) at Spike 655 are colored in yellow. B) Counts of
SARS-CoV-2 viruses that contain Spike H655Y, broken down by country. C) Map highlighting
the number viruses from each country. The size of the circle represents the number of
sequences from the appropriate country contained in the phylogeny.
(TIF)
S6 Fig. Read depth across the SARS-CoV-2 genome in index cats. Each day is represented
by a different color. Replicate A is shown in the left column and replicate B is shown in the
right column.
(TIF)
S7 Fig. Read depth across the SARS-CoV-2 genome in contact cats. Each day is represented
by a different color. Replicate A is shown in the left column and replicate B is shown in the
right column.
(TIF)
S8 Fig. Intersection variants found across technical replicates in index cats. The frequency
of each variant per replicate is shown here. The diagonal line represents the 1:1 intersection of
replicate variants. The subplot to the right of each primary plot is a zoomed-in view of the low-
frequency variants (3–15%). Each timepoint is denoted by a different color.
(TIF)
S9 Fig. Intersection variants found across technical replicates in contact cats. The fre-
quency of each variant per replicate is shown here. The diagonal line represents the 1:1 inter-
section of replicate variants. The subplot to the right of each primary plot is a zoomed-in view
of the low-frequency variants (3–15%). Each timepoint is denoted by a different color.
(TIF)
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S10 Fig. Longitudinal pairwise nonsynonymous nucleotide diversity divided by pairwise
synonymous nucleotide diversity in index cats. Line color denotes gene. The horizontal dot-
ted gray line is plotted at y = 1 or when πN ~ πS.
(TIF)
S11 Fig. Longitudinal pairwise nonsynonymous nucleotide diversity divided by pairwise
synonymous nucleotide diversity in contact cats. Line color denotes gene. The horizontal
dotted gray line is plotted at y = 1 or when πN ~ πS.
(TIF)
S12 Fig. SARS-CoV-2 spike glycoprotein crystal structure. Spike H655Y is highlighted in
blue. The table to the right of the crystal structure includes summary information regarding
the impact of a histidine to tyrosine change on amino acid charge, volume, and aromaticity. �
Qualitative definitions of radical amino acid replacements, based on three alternative residue
groupings, see Hanada et al., 2006 [68]. The crystal structure and summary information were
generated using GISAID’s CoVserver mutation analysis tool.
(TIF)
S1 Table. Nonsynonymous and synonymous nucleotide diversity estimates in index cats.
(PDF)
S2 Table. Genome-wide pairwise nucleotide diversity estimates in index and contact cats.
(PDF)
S3 Table. ARTIC v3 primer sequences.
(PDF)
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